2[2]Matsunaga N, Yamada N, Ohira M, et al. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer[J]. Oncol Rep, 2004,11∶167-171.
3[3]Stoeltzing O, Liu W, Reinmuth N, et al. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis[J]. Ann Surg Oncol, 2003,10∶722-733.
4[4]Wanebo HJ, Semoglou C, Attiyeh F, et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases[J]. Am J Surg, 1978,135∶81-85.
5[5]Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer[J]. Ann Surg, 1984,199∶502-508.
6[6]Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis[J]. J Am Coll Surg, 2003,197∶233-241.
7[7]Cady B, Jenkins RL, Steele GD Jr, et al. Surgical mar- gin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome[J]. Ann Surg, 1998,227∶566-571.
8[8]Wanebo H J, Chu QD, Vezeridis MP, et al. Patient selection for hepatic resection of colorectal metastases[J]. Arch Surg, 1996,131∶322-329.
9[9]Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients[J]. Cancer, 1996,77∶1254-1262.
10[10]Kemeny MM, sudeshan A, gray B, et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy:An intergroup study[J]. J Clin Oncol, 2002,20∶1499-1505.
5Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg, 2000;232(2) : 58.
6Roland M,Adrea L,Jurgen L,et al. Cytokeratin 20 in human carcinoma. Am J Path, 1992; 140 : 427.
7Funaki NO, Tanaka J, Itami A, et al. Dection of colorectal carcinoma cells in circulating peripheral blood by reverse trascription-polmerase chain reaction targeting cytokertin 20mRNA. Life Sci, 1997 ; 60 (3): 1035.
8Funakl N , Tanaka J, Ohshio G ,et al. Cytokeratin 20mRNA in peripheral venous blood of colorectal carcinoma patients. British Journal of Carcioma,1998; 77(8): 1327.
